Q News and Research

RSS

NIH grant supports research on cognitive decline in individuals with Lewy body diseases

Penn Medicine researchers will advance their understanding of the underlying causes of cognitive decline in individuals with Lewy body diseases, like Parkinson's, and identify biomarkers that predict which individuals are more likely to develop dementia with a $18 million grant from the National Institutes of Health/National Institute on Aging.

30 Sep 2024

The Medicare Advantage influence machine

Federal officials resolved more than a decade ago to crack down on whopping government overpayments to private Medicare Advantage health insurance plans, which were siphoning off billions of tax dollars every year.

30 Sep 2024

Democratic hopefuls fault GOP incumbents for anti-abortion records in Congress

In a campaign ad this month, Derek Tran, a Democrat from Orange County, California, blasted his opponent, Republican U.S. Rep. Michelle Steel, for supporting a national abortion ban and voting to limit access to birth control.

27 Sep 2024

Digital games show promise for improving ADHD and depression in youth, but anxiety remains a challenge

A meta-analysis reveals gamified digital mental health interventions effectively reduce depression and ADHD in youth, highlighting engagement in treatment.

27 Sep 2024

Revolutionary blueprint aims to enhance nurse's impact on patient outcomes

A groundbreaking article published in the latest issue of Nursing Outlook proposes a significant shift in how nursing care is measured within acute and critical care settings.

26 Sep 2024

Study sheds light on mechanisms behind liver fibrosis and potential therapies

New research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis and suggests a novel treatment approach for this common and serious condition.

25 Sep 2024

Researchers identify drug with anti-aging effects

Aging is an inevitable phenomenon and is accompanied by several comorbidities. To this end, research into the effects of aging has become paramount, and scientists are looking for ways to slow down aging and its detrimental impact on the human body.

25 Sep 2024

Study links youth prediabetes to increased pregnancy risks later in life

New research conducted at Columbia Mailman School of Public Health and Mount Sinai School of Medicine shows a link between prediabetes among young people and adverse pregnancy outcomes later in life.

24 Sep 2024

Innovative HiTIP-seq method advances epigenetic research in pediatric brain tumors

Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical regions of the central nervous system, such as the pons, thalamus, and spinal cord.

24 Sep 2024

Cardiovascular disease pathways associated with psoriasis, but not other immune-mediated diseases

A genetic connection between cardiovascular disease and psoriasis highlights shared inflammatory pathways, emphasizing the need for cardiovascular monitoring.

19 Sep 2024

IVF transfer day does not impact overall success rates, study reveals

In IVF treatment, embryos are traditionally transferred in the uterus three days after fertilization. Due to improvements in laboratory techniques, this is now also possible after five days.

17 Sep 2024

Post-treatment lifestyle choices influence long-term outcomes in breast cancer patients

Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer.

17 Sep 2024

ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit from adding immunotherapy to current standard treatments, while a first-in-human study found 'promising' antitumor activity with a novel antibody drug conjugate (ADC) targeting the protein claudin 6 in heavily pretreated patients with ovarian and endometrial cancers.

16 Sep 2024

High-dose vitamin D3 cannot be recommended as treatment for metastatic colon cancer

A double-blind randomized phase 3 clinical trial led by Dana-Farber Cancer Institute researchers and conducted across several hundred cancer centers in the U.S. tested the addition of high-dose vitamin D3 to standard treatment for patients with untreated metastatic colorectal cancer.

16 Sep 2024

Evolution of vaccine adjuvants from empirical discovery to rational design

Vaccine adjuvants have evolved significantly since their inception, transitioning from empirical discovery to a more structured approach grounded in rational drug design.

13 Sep 2024

New drug shows strong activity against brain metastases in HER2-positive breast cancer

A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced HER2-positive breast cancer.

13 Sep 2024

Trial finds no benefit of adding nivolumab to tivozanib for advanced kidney cancer

In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the addition of the immune checkpoint inhibitor (ICI) nivolumab to treatment with tivozanib for patients with advanced clear cell renal cell carcinoma, a form of kidney cancer.

13 Sep 2024

Study finds brain synchronization between humans and dogs during social interactions

During social interactions, the activity of the brain's neurons becomes synchronized between the individuals involved.

13 Sep 2024

New molecular map offers insights into human physiology and disease

Scientists at Weill Cornell Medicine in Qatar (WCM-Q) have created an intricate molecular map of the human body and its complex physiological processes based on the analysis of thousands of molecules measured in blood, urine and saliva samples from 391 volunteers.

11 Sep 2024

Longtime head of L.A. Care to retire after navigating major Medi-Cal changes

For nearly a decade, John Baackes has led L.A. Care Health Plan, a publicly run insurer primarily serving low-income Los Angeles County residents on Medi-Cal. It is by far the largest Medi-Cal plan in the state.

11 Sep 2024

Q News and Research

NIH grant supports research on cognitive decline in individuals with Lewy body diseases

The Medicare Advantage influence machine

Democratic hopefuls fault GOP incumbents for anti-abortion records in Congress

Digital games show promise for improving ADHD and depression in youth, but anxiety remains a challenge

Revolutionary blueprint aims to enhance nurse's impact on patient outcomes

Study sheds light on mechanisms behind liver fibrosis and potential therapies

Researchers identify drug with anti-aging effects

Study links youth prediabetes to increased pregnancy risks later in life

Innovative HiTIP-seq method advances epigenetic research in pediatric brain tumors

Cardiovascular disease pathways associated with psoriasis, but not other immune-mediated diseases

IVF transfer day does not impact overall success rates, study reveals

Post-treatment lifestyle choices influence long-term outcomes in breast cancer patients

ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

High-dose vitamin D3 cannot be recommended as treatment for metastatic colon cancer

Evolution of vaccine adjuvants from empirical discovery to rational design

New drug shows strong activity against brain metastases in HER2-positive breast cancer

Trial finds no benefit of adding nivolumab to tivozanib for advanced kidney cancer

Study finds brain synchronization between humans and dogs during social interactions

New molecular map offers insights into human physiology and disease

Longtime head of L.A. Care to retire after navigating major Medi-Cal changes

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News